Skip to main content
. 2021 Jun 18;37:100974. doi: 10.1016/j.eclinm.2021.100974

Table 1.

Baseline characteristics according to lung function in 108 246 individuals in the general population.

Below normal lung function (n = 12 364) Normal lung function (n = 91 938) Supernormal lung function (n = 3944)
Age – years 61·0 (51·8–69·3)* 57·9 (47·9–67·2) 53·4 (44·3–65·6)*,
Male sex – no. (%) 5738 (46)* 41 504 (45) 1429 (36)*,
Weight – kg 77·7 (66·7–90·0)* 75·5 (65·7–86·1) 73·5 (64·7–83·7)*,
Height – cm 171 (165–178) 171 (165–178) 172 (165–179)*,
BMI – kg/m2 26·3 (23·4–29·7)* 25·5 (23·2–28·3) 24·9 (22·8–27·2)*,
Lung function
 FEV1 – L 2·02 (1·58–2·47)* 3·00 (2·49–3·60) 3·90 (3·39–4·69)*,
 FEV1% predicted –% 69 (60–75)* 98 (90–106) 126 (122–132)*,
 FVC – L 2·94 (2·39–3·57)* 3·87 (3·24–4·64) 4·80 (4·19–5·81)*,
 FVC% predicted –% 78 (70–85)* 101 (92–109) 125 (119–132)*,
 FEV1/FVC 0·69 (0·61–0·76)* 0·78 (0·74–0·82) 0·81 (0·78–0·84)*,
Smoking information
 Never-smokers – no. (%) 2960 (24)* 40 292 (44) 2026 (51)*,
 Former smokers – no. (%) 5096 (41) 37 429 (41) 1575 (40)
 Current smokers – no. (%) 4276 (35)* 13 851 (15) 321 (8)*,
 Unknown– no. (%) 32 (<1)* 366 (<1) 22 (<1)
 Tobacco consumption – pack-years 30·0 (15·0–44·0)* 14·8 (5·3–27·7) 7·5 (2·8–15·0)*,
Poor socioeconomic status – no. (%) 3634 (29)* 15 161 (16) 524 (13)*,
Asthma – no. (%) 1935 (16)* 4519 (5) 104 (3)*,
Treatment with airway medication – no. (%) 2359 (19)* 4048 (4) 94 (2)*,

Data presented as median (25th and 75th percentiles), or number (percent). Numbers may not sum to 100 due to rounding. Based on the Copenhagen General Population Study. BMI=body mass index. FEV1=forced expiratory volume in 1 sec. FVC=forced vital capacity.

P < 0·05 for comparison with normal lung function using Wilcoxon's rank sum or Pearson's chi-squared test.

P < 0·05 for comparison with below normal lung function using Wilcoxon's rank sum or Pearson's chi-squared test.

Includes only current and former smokers.